By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Research and development of potential therapeutics for cancers, viruses and autoimmune disorders88K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States88K100.00%